Author + information
- Received July 8, 2009
- Revision received September 4, 2009
- Accepted September 21, 2009
- Published online March 2, 2010.
- C. Jan Willem Borleffs, MD,
- Johannes B. van Rees, MD,
- Guido H. van Welsenes, MS,
- Enno T. van der Velde, PhD,
- Lieselot van Erven, MD, PhD,
- Jeroen J. Bax, MD, PhD and
- Martin J. Schalij, MD, PhD⁎ ()
- ↵⁎Reprint requests and correspondence:
Dr. Martin J. Schalij, Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands
Objectives This study aimed to assess the prevalence of different types of atrial fibrillation (AF) and their prognostic importance in implantable cardioverter-defibrillator (ICD) patients.
Background The prevalence of AF has taken epidemic proportions in the population with cardiovascular disease. The prognostic importance of different types of AF in ICD patients remains unclear.
Methods Data on 913 consecutive patients (79% men, mean age 62 ± 13 years) receiving an ICD at the Leiden University Medical Center were prospectively collected. Among other characteristics, the existence and type of AF (paroxysmal, persistent, or permanent) were assessed at implantation. During follow-up, the occurrence of appropriate or inappropriate device therapy as well as mortality was noted.
Results At implantation, 73% of patients had no history of AF, 9% had a history of paroxysmal AF, 7% had a history of persistent AF, and 11% had permanent AF. During 833 ± 394 days of follow-up, 117 (13%) patients died, 228 (25%) patients experienced appropriate device discharge, and 139 (15%) patients received inappropriate shocks. Patients with permanent AF exhibited more than double the risk of mortality, ventricular arrhythmias triggering device discharge, and inappropriate device therapy. Patients with paroxysmal or persistent AF did not show a significant increased risk of mortality or appropriate device therapy but demonstrated almost 3 times the risk of inappropriate device therapy.
Conclusions In the population currently receiving ICD treatment outside the setting of clinical trials, a large portion has either a history of AF or permanent AF. Both types of AF have prognostic implications for mortality and appropriate as well as inappropriate device discharge.
- atrial fibrillation
- implantable cardioverter-defibrillator
- ventricular arrhythmia
Dr. Bax has received research grants from GE Healthcare, Bristol-Myers Squibb Medical Imaging, Edwards Lifesciences, Boston Scientific, Biotronik, Medtronic, and St. Jude. Dr. Schalij has received research grants from Biotronik, Medtronic, and Boston Scientific. James Daubert, MD, served as Guest Editor for this article.
- Received July 8, 2009.
- Revision received September 4, 2009.
- Accepted September 21, 2009.
- American College of Cardiology Foundation